{
  "main_header": {
    "sid": 1118122,
    "name": "Shandong Buchang Pharmaceuticals Co., Ltd.",
    "stock_name": "Shandong Buchang Pharmaceuticals Co., Ltd.",
    "full_name": "Shandong Buchang Pharmaceuticals Co., Ltd.",
    "name_url": "stocks-analysis/shandong-buchang-pharmaceuticals-co-",
    "exchange": 47,
    "exchangecode": "SHG",
    "country_id": 12,
    "currency": "CNY",
    "cmp": "16.91",
    "chg": -0.05,
    "chgp": "-0.29%",
    "dir": -1,
    "prev_price": "16.96",
    "mcapval": "20,152.10",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "China Shanghai Composite",
    "isin": "CNE100002FV6",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "6.27 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shandong-buchang-pharmaceuticals-co--1118122-47&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Shandong Buchang Pharmaceuticals Reports Strong Quarterly Profits Amidst Market Challenges",
        "link": "https://www.marketsmojo.com/news/mojo-premium/shandong-buchang-pharmaceuticals-co-ltd-joins-momentum-now-strategy-for-strong-financial-performance-3718502",
        "imagepath": "",
        "date": "2025-11-20 15:51:37",
        "description": "<p><strong>Shandong Buchang Pharmaceuticals Co., Ltd.</strong>, a prominent player in the pharmaceuticals and biotechnology sector, has recently released its financial results for the quarter ending March 2025. Despite facing a challenging market environment, the company has demonstrated resilience with notable performance metrics.</p>\n\n<p>In the latest quarter, <strong>Shandong Buchang Pharmaceuticals</strong> achieved an operating profit of CNY 377.47 MM, marking a significant milestone for the company. This figure represents the highest operating profit recorded in recent times, showcasing the company's ability to maintain profitability even in adverse conditions.</p>\n\n<p>Additionally, the pre-tax profit reached CNY 373.97 MM, further underscoring the company's robust financial health. The net profit for the quarter also hit a record high of CNY 305.66 MM, reflecting effective cost management and operati..."
      }
    ],
    "total": 1,
    "sid": "1118122",
    "stock_news_url": "https://www.marketsmojo.com/news/shandong-buchang-pharmaceuticals-co--1118122"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Shandong Buchang Pharmaceuticals Reports Strong Quarterly Profits Amidst Market Challenges

2025-11-20 15:51:37

Shandong Buchang Pharmaceuticals Co., Ltd., a prominent player in the pharmaceuticals and biotechnology sector, has recently released its financial results for the quarter ending March 2025. Despite facing a challenging market environment, the company has demonstrated resilience with notable performance metrics.

In the latest quarter, Shandong Buchang Pharmaceuticals achieved an operating profit of CNY 377.47 MM, marking a significant milestone for the company. This figure represents the highest operating profit recorded in recent times, showcasing the company's ability to maintain profitability even in adverse conditions.

Additionally, the pre-tax profit reached CNY 373.97 MM, further underscoring the company's robust financial health. The net profit for the quarter also hit a record high of CNY 305.66 MM, reflecting effective cost management and operati...

Read More

View All News